Replay available

Daiichi Sankyo Co Ltd Ord (DSKYF) Q3 2025 Earnings Call

Daiichi Sankyo Co Ltd Ord (OTC: DSKYF) Q3 2025 earnings conference call, held 2025-12-30. Replay captured from the company's public earnings webcast.

Tue, December 30, 2025 at 1:00 AMendedReplay
Daiichi Sankyo Co Ltd Ord (DSKYF) Q3 2025 Earnings Call

Hosted by

Featured presenters

Mr. Ogawa

Senior Executive Officer, CFO

Mr. Abe

Head of R&D Division

Mr. Ken Keller

Head of Global Oncology Business

Man Megano

Analyst, BofA Securities

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Daiichi Sankyo Company, Limited.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:01.600 -- 00:00:03.123 Ladies 00:00:03.123 -- 00:00:05.588 and gentlemen, thank you very much for your patience. 00:00:05.588 -- 00:00:08.814 Now we would like to start FI 2025 00:00:08.814 -- 00:00:11.519 third quarter financial results presentation. 00:00:11.519 -- 00:00:15.367 I am from corporate communication. My name is Asakura. 00:00:15.367 -- 00:00:20.515 I will be facilitating today's session. In this presentation, we are going to use 00:00:20.515 -- 00:00:25.681 Japanese and English. We have simultaneous interpretation service available. 00:00:25.681 -- 00:00:30.967 Please click on the interpretation icon at the bottom of the screen and please select 00:00:30.967 -- 00:00:35.853 the language of your choice. If you choose original audio, you should be able to hear 00:00:35.853 -- 00:00:40.859 original audio. And then on the Zoom screen, on the live streaming, we are 00:00:40.859 -- 00:00:44.395 going to put up Japanese presentation material. 00:00:44.395 -- 00:00:49.466 we have uploaded Japanese and English presentation material 00:00:49.466 -- 00:00:54.677 in our library on our corporate website whenever necessary 00:00:54.677 -- 00:00:59.709 please feel free to download the material Today's presenters 00:00:59.709 -- 00:01:04.274 are Mr. Ogawa, Senior Executive Officer, CFO, Mr. 00:01:04.274 -- 00:01:09.580 Abe, Head of R&D Division, and Mr. Ken Keller, Head of Global Oncology 00:01:09.580 -- 00:01:14.826 Business. Now, Ogawa and Abe are going to take you through the financial results 00:01:14.826 -- 00:01:17.690 for the third quarter FI 2025, 00:01:17.690 -- 00:01:20.693 and then we are going to open the floor for the Q&A. 00:01:20.693 -- 00:01:24.978 Today's session will be recorded. I would like to ask for your cooperation. 00:01:24.978 -- 0...